Objective To discuss the problems existing in the compensation of Chinese clinical trial participants and propose some suggestions for improving their rights.Methods The literature related to the participants’right t...Objective To discuss the problems existing in the compensation of Chinese clinical trial participants and propose some suggestions for improving their rights.Methods The literature related to the participants’right to compensation at home and abroad was searched to study the inadequacy of the compensation right for clinical trial participants in China from four aspects:insurance system,principle of attribution,legal relationship and compensation regulations.Then,some suggestions to improve the participants’right to compensation were proposed.Results and Conclusion China lacks clear legal norms for participants’right to compensation.There are problems such as unclear insurance rules and compensation rules,unclear contractual relationships between parties to clinical trials,and no laws and regulations to rely on for attribution and compensation.China should issue regulatory guidelines related to the right to compensation of participants in clinical trials,so that all parties in clinical trials can have rules to follow if there is the occurrence of injury,which can better protect the rights and interests of the participants.展开更多
黑桫椤(Gymnosphaera podophylla Dalla Torre&Sarnth.)为著名的孑遗蕨类,具有很强的环境适应能力,然而其适应性机制尚不清楚。本研究采用PacBio和Illumina技术对黑桫椤的根、羽轴和羽片进行转录组测序,分别生成12879、14185和1608...黑桫椤(Gymnosphaera podophylla Dalla Torre&Sarnth.)为著名的孑遗蕨类,具有很强的环境适应能力,然而其适应性机制尚不清楚。本研究采用PacBio和Illumina技术对黑桫椤的根、羽轴和羽片进行转录组测序,分别生成12879、14185和16084个全长unigenes。基因表达分析结果表明,与黑桫椤抗干旱、缺水胁迫和生物胁迫相关的基因表达水平较高。根、羽轴和羽片特异性上调基因均显著富集到KEGG代谢通路中的“苯丙烷生物合成途径”,根和羽轴的器官特异性上调基因还显著富集到“类黄酮生物合成途径”。共有192个全长unigenes被注释为类黄酮生物合成途径所涉及的13个酶结构基因,其中包括112个差异表达基因(DEGs),表明黑桫椤类黄酮生物合成途径较为保守,且存在器官特异性差异表达基因。本文对黑桫椤多器官全长转录组和类黄酮生物合成途径结构基因进行了综合分析,为进一步研究其对环境的适应性提供了丰富的遗传资源。展开更多
基金Liaoning Pharmaceutical Industry Innovation and Development Strategy Research and Funding Project(2020lslktyb-095)National Medical Products Administration-Special Fund of Drug Regulatory Research Institute of Shenyang Pharmaceutical University(2021jgkx004)+1 种基金Shenzhen Maternity&Child Healthcare Hospital Science Foundation(2022(73))Shenzhen Health Economics Society Research Fund Project(202333).
文摘Objective To discuss the problems existing in the compensation of Chinese clinical trial participants and propose some suggestions for improving their rights.Methods The literature related to the participants’right to compensation at home and abroad was searched to study the inadequacy of the compensation right for clinical trial participants in China from four aspects:insurance system,principle of attribution,legal relationship and compensation regulations.Then,some suggestions to improve the participants’right to compensation were proposed.Results and Conclusion China lacks clear legal norms for participants’right to compensation.There are problems such as unclear insurance rules and compensation rules,unclear contractual relationships between parties to clinical trials,and no laws and regulations to rely on for attribution and compensation.China should issue regulatory guidelines related to the right to compensation of participants in clinical trials,so that all parties in clinical trials can have rules to follow if there is the occurrence of injury,which can better protect the rights and interests of the participants.
文摘黑桫椤(Gymnosphaera podophylla Dalla Torre&Sarnth.)为著名的孑遗蕨类,具有很强的环境适应能力,然而其适应性机制尚不清楚。本研究采用PacBio和Illumina技术对黑桫椤的根、羽轴和羽片进行转录组测序,分别生成12879、14185和16084个全长unigenes。基因表达分析结果表明,与黑桫椤抗干旱、缺水胁迫和生物胁迫相关的基因表达水平较高。根、羽轴和羽片特异性上调基因均显著富集到KEGG代谢通路中的“苯丙烷生物合成途径”,根和羽轴的器官特异性上调基因还显著富集到“类黄酮生物合成途径”。共有192个全长unigenes被注释为类黄酮生物合成途径所涉及的13个酶结构基因,其中包括112个差异表达基因(DEGs),表明黑桫椤类黄酮生物合成途径较为保守,且存在器官特异性差异表达基因。本文对黑桫椤多器官全长转录组和类黄酮生物合成途径结构基因进行了综合分析,为进一步研究其对环境的适应性提供了丰富的遗传资源。